Patents by Inventor Myunghyo HONG

Myunghyo HONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acetyl-CoA carbosylase2 antisense oligonucleotides
    Patent number: 11739124
    Abstract: The present invention provides the peptide nucleic acid derivative which targets 5? splice site of the human ACC2 pre-mRNA “exon 12”. The peptide nucleic acid derivatives in the present invention strongly induce splice variants of the human ACC2 mRNA in cell and are very useful to treat conditions or disorders of skin aging associated with the human ACC2 protein.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: August 29, 2023
    Assignee: OLIPASS CORPORATION
    Inventors: Seon-Young Han, Kiho Sung, Myunghyo Hong, Dayoung Kang, Jeong-Seok Heo, Kang Won Jang
  • ACETYL-COA CARBOXYLASE2 ANTISENSE OLIGONUCLEOTIDES
    Publication number: 20210363190
    Abstract: The present invention provides the peptide nucleic acid derivative which targets 5? splice site of the human ACC2 pre-mRNA “exon 12”. The peptide nucleic acid derivatives in the present invention strongly induce splice variants of the human ACC2 mRNA in cell and are very useful to treat conditions or disorders of skin aging associated with the human ACC2 protein.
    Type: Application
    Filed: August 5, 2019
    Publication date: November 25, 2021
    Inventors: Seon-Young HAN, Kiho SUNG, Myunghyo HONG, Dayoung KANG, Jeong-Seok HEO, Kang Won JANG
  • MATRIX METALLOPROTEINASE-1 ANTISENSE OLIGONUCLEOTIDES
    Publication number: 20210292369
    Abstract: A method to treat diseases or conditions associated with the human MMP-1 gene transcription involving administration of the peptide nucleic acid derivative according to claim 1 to a subject. The present invention provides the peptide nucleic acid derivative according to claim 1 which targets 5? splice site of the human MMP-1 pre-mRNA “exon 5”. The peptide nucleic acid derivatives in the present invention strongly induce splice variants of the human MMP-1 mRNA in cell and are very useful to treat conditions or diseases of skin aging associated with the human MMP-1 protein.
    Type: Application
    Filed: May 3, 2019
    Publication date: September 23, 2021
    Inventors: Seon-Young HAN, Kiho SUNG, Myunghyo HONG, Youree OH, Jeong-Seok HEO, Kang Won JANG